Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion
LON:CNSL

Cambridge Nutritional Sciences 11/21/2024 Earnings Report

GBX 1.94 0.00 (0.00%)
As of 05/18/2026 05:59 AM Eastern

Cambridge Nutritional Sciences EPS Results

Actual EPS
-GBX 0.10
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cambridge Nutritional Sciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cambridge Nutritional Sciences Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Cambridge Nutritional Sciences Earnings Headlines

Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel
See More Cambridge Nutritional Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cambridge Nutritional Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cambridge Nutritional Sciences and other key companies, straight to your email.

About Cambridge Nutritional Sciences

Cambridge Nutritional Sciences (LON:CNSL) (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

View Cambridge Nutritional Sciences Profile